Progress towards the elimination of trachoma in Nigeria
- PMID: 38815996
- PMCID: PMC11697179
- DOI: 10.1093/inthealth/ihae035
Progress towards the elimination of trachoma in Nigeria
Abstract
Trachoma is targeted for elimination as a public health problem worldwide by 2030. In Nigeria, elimination activities are implemented at the local government area (LGA) level. They started in 2002 by conducting baseline population-based prevalence surveys (PBPSs), which continued in a systematic manner with engagement from the Global Trachoma Mapping Project in 2013, and subsequently Tropical Data. The results led to the development of Nigeria's first trachoma action plan and its subsequent revision with additional information. Following 449 baseline PBPSs, 122 LGAs had an active trachoma prevalence above the elimination threshold, requiring interventions, while 231 LGAs required community-based interventions for trichiasis management. By 2021, >34 million antibiotic treatments had been provided in 104 LGAs, with 89 LGAs eliminating active trachoma. Nationally, water and sanitation coverages increased by 3% and 18%, respectively, in 7 y. Systematic trichiasis case finding and management were carried out in 231 LGAs, resulting in the management of 102 527 people. Fifty-four LGAs decreased trichiasis prevalence unknown to the health system to <0.2% in persons ≥15 y of age. Where this elimination prevalence threshold was reached, trichiasis services were transitioned to routine eye/healthcare systems. Such progress relied on strong leadership and coordination from the national trachoma program and tremendous support provided by partners. Attaining elimination of trachoma as a public health problem in Nigeria by 2030 is feasible if funding support is sustained.
Keywords: Nigeria; elimination; neglected tropical diseases; trachoma; trichiasis.
© The Author(s) 2024. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.
Conflict of interest statement
AB and SB are employed by ITI, which receives an operating budget and research funding from Pfizer, the manufacturers of Zithromax (azithromycin). EMHE receives salary support from ITI.
Figures




Comment in
-
Tropical Data: supporting health ministries worldwide to conduct high-quality trachoma surveys.Int Health. 2025 Jan 3;17(1):1-3. doi: 10.1093/inthealth/ihae036. Int Health. 2025. PMID: 38815986 Free PMC article. No abstract available.
References
-
- World Health Organization . Future approaches to trachoma control: report of a global scientific meeting, Geneva, 17–20 June 1996. WHO/PBL/96.56. Geneva: World Health Organization; 1997.
-
- World Health Organization . Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030. Geneva: World Health Organization; 2020. Available from: https://apps.who.int/iris/handle/10665/338565 [accessed 28 January 2021].
-
- Francis V, Turner V. Achieving community support for trachoma control. WHO/PBL/93.36. Geneva: World Health Organization; 1993.
-
- World Health Organization . WHO Alliance for the Global Elimination of Trachoma: progress report on elimination of trachoma, 2021. Wkly Epidemiol Rec. 2023;98(28):297–314.
-
- World Health Organization . Validation of elimination of trachoma as a public health problem. WHO/HTM/NTD/2016.8. Geneva: World Health Organization; 2016.